RxDoctor Payments Data

Kevin Fitzgerald, MD

Family Medicine · Stuart, FLNPI 1891923744

Payments from drug & device makers

$197,634in general payments, 2019–2025

Across 166 payments — averaging $1190.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CSL Behring$126K
  • CSL Plasma Inc.$71K
  • Johnson & Johnson$524
  • AMAG Pharmaceuticals, Inc.$125
  • Seagen Inc.$92
  • Sumitomo Pharma America, Inc.$69
  • plus $89 from 3 others

What the payments were for

  • Consulting fees$196,735100%
  • Food & beverage$8990%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
CSL Behring101$125,725
CSL Plasma Inc.49$71,010
Johnson & Johnson8$524
AMAG Pharmaceuticals, Inc.1$125
Seagen Inc.1$92
Sumitomo Pharma America, Inc.3$69
AstraZeneca1$50
180 Medical, Inc.1$25
Pfizer1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$197,634 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$7,295
Medicare patients
28
Services billed
72

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib32$533
Cyclobenzaprine Hcl46$227

Paid to pharmacies, not to this prescriber.

Other family medicine in Stuart

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →